Aritro Nath, Ph.D.

Dr. Aritro Nath is an Assistant Professor in the Department of Medical Oncology & Therapeutics Research at City of Hope National Medical Center. His research integrates experimental and computational biology, artificial intelligence (AI), and clinical data science to advance precision oncology. By leveraging large-scale electronic health records, genomic datasets, clinical trials, and real-world evidence, his work seeks to uncover the mechanisms driving cancer progression, therapeutic resistance, and disease evolution, while developing clinically actionable biomarkers and predictive models that improve patient stratification and treatment decision-making.

Dr. Nath leads the Precision Oncology Laboratory at City of Hope, a multidisciplinary research program focused on translating complex patient and molecular data into meaningful clinical insights. Working closely with disease teams across the institution, his laboratory develops AI-enabled analytic frameworks, digital biomarkers, and precision medicine strategies across multiple cancer types, including lung cancer, breast cancer, glioblastoma, ovarian cancer, and acute myeloid leukemia. His research spans mechanistic studies, computational method development, and the clinical evaluation of biomarkers to improve patient outcomes.

Dr. Nath received his PhD in Genetics from Michigan State University and completed postdoctoral training in translational pharmacogenomics. He established the Precision Oncology Laboratory at City of Hope in 2023, where his team combines systems biology, artificial intelligence, and translational oncology to accelerate the development of next-generation precision medicine approaches for cancer patients.